Roche Czech Republic's total assets reached CZK 2,647 mil at the end of 2016, up 3.87% compared to the previous year.
Current assets amounted to CZK 2,276 mil, or 86.0% of total assets while cash stood at CZK 0.013 mil at the end of 2016.
By contrast, total debt reached CZK 203 mil at the year-end, or 7.69% of total assets, while the firm's equity amounted to CZK 1,436 mil. As a result, net debt stood at CZK 203 mil at the end of 2016 and accounted for 14.2% of equity.
Net debt against equity is up 14.2 pp from five years ago (-0.035%). The ratio against EBITDA increased from -0.002x seen in 2011 to 0.428x.
The company’s cost of funding amounted to 0.420% in 2016, up 0.566 pp compared to the average over the last 5 years.
You can see all the company’s data at Roche Czech Republic profile, or you can download a report on the company in the report section.